DXCM

DexCom Inc.

Price

$87.90

return (12m)

9.18%

p/e

33.80

p/bv

12.89

DIVIDEND YIELD

0.00%

DXCM price

DexCom

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment DXCM

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.37%

3 months

12.42%

1 year

9.18%

2 years

26.09%

5 years

-36.38%

10 years

277.90%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals DXCM

Valuation

P/E

33.80

Sector 0.57

Industry 6.93

P/BV

12.89

Sector 1.90

Industry 1.33

P/Revenue (PSR)

6.80

Sector 1.58

Industry 0.55

EV/EBITDA

81.93

Sector -48.61

Industry -38.44

EV/EBIT

99.37

Sector -28.36

Industry 7.97

P/EBITDA

21.68

Sector -38.03

Industry -4.41

P/EBIT

26.10

Sector -43.90

Industry -3.47

P/Total Assets

5.24

Sector 0.90

Industry 0.56

P/Net Current Assets

133.73

Sector -23.20

Industry -12.23

P/Working Capital

19.55

Sector -4.39

Industry -49.24

EPS

2.62

Sector -0.70

Industry -0.47

BVPS

6.86

Sector 4.03

Industry 6.07

Efficiency

Gross Margin

62.47%

Sector 49.10%

Industry 45.93%

EBITDA Margin

29.71%

Sector -313.26%

Industry -72.01%

EBIT Margin

24.50%

Sector -182.06%

Industry -10.15%

Operating Margin

22.92%

Sector -20.87%

Industry -5.34%

Net Profit Margins

20.12%

Sector -25.33%

Industry -14.94%

Asset Turnover

0.20

Sector 0.13

Industry 0.22

Profitability

ROE

38.14%

Sector -25.69%

Industry -28.63%

ROA

15.49%

Sector -25.32%

Industry -14.95%

ROIC

41.36%

Sector -589.68%

Industry -110.50%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

1.73

Sector 1.89

Industry 1.14

Net Debt / EBITDA

-5.01

Sector -21.45

Industry -31.77

Net Debt / EBIT

-6.07

Sector -3.01

Industry 2.06

Net Debt / Equity

-0.74

Sector -0.62

Industry 0.01

Gross Debt / Equity

0.00

Sector 0.11

Industry 0.46

Equity/Assets

0.41

Sector 0.45

Industry 0.30

Liabilities/Assets

0.59

Sector 0.49

Industry 0.60

Growth

5Y Revenue CAGR

15.21%

Sector -

Industry -

5Y Earnings CAGR

35.74%

Sector -

Industry -

Fundamentals DXCM

DRAG THE FRAME TO SEE MORE DATA

FAIR VALUE OF DexCom ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$87.90

Fair Value

$20.11

Upside Return potential.

-77.12%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
DXCM DexCom Inc.	$87.90	9.18%	0.00%	33.80	12.89	38.14%	20.12%
ISRG Intuitive Surgical Inc.	$365.46	-17.16%	0.00%	40.98	7.07	17.26%	28.62%
ABT Abbott Laboratories	$105.70	-18.22%	2.25%	35.46	3.76	10.61%	11.65%
MDT Medtronic PLC	$92.65	3.78%	3.04%	22.82	2.36	10.35%	14.02%
BSX Boston Scientific Corp.	$45.82	-57.27%	0.00%	19.32	2.85	14.73%	17.49%
TMDX TransMedics Group Inc.	$88.23	-15.18%	0.00%	19.90	5.83	29.28%	22.69%
RMD ResMed Inc.	$221.30	-19.11%	1.06%	21.68	5.07	23.41%	27.44%
IDXX IDEXX Laboratories Inc.	$525.66	-18.25%	0.00%	36.90	26.08	70.67%	25.03%
COHR Coherent Inc.	$281.86	188.08%	0.00%	118.83	4.88	4.11%	6.85%
SYK Stryker Corp.	$280.78	-27.51%	1.15%	31.24	4.86	15.55%	14.43%
PHG Koninklijke Philips NV	$25.37	-5.59%	3.89%	19.20	1.88	9.80%	6.30%
INMD InMode Ltd.	$14.91	-0.47%	0.00%	11.32	1.39	12.32%	20.69%
BDX Becton Dickinson and Company	$179.74	-3.76%	2.24%	54.57	2.11	3.86%	6.30%
EW Edwards Lifesciences Corp.	$86.69	7.10%	0.00%	51.58	4.83	9.36%	15.41%
ALGN Align Technology Inc.	$154.02	10.71%	0.00%	27.43	2.68	9.77%	9.99%
IRMD iRadimed Corporation	$84.40	20.92%	1.50%	46.80	10.60	22.66%	26.70%
SNN Smith & Nephew PLC	$27.85	-24.38%	2.68%	20.30	4.71	23.22%	9.83%
ZBH Zimmer Biomet Holdings Inc.	$92.89	-11.21%	0.97%	23.50	1.50	6.39%	9.48%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

DXCM Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT DexCom

DexCom Inc.

Average Investor10 user rating

4.0 (17 people)

United States

27 years

Founded: 1999

2005

Time since IPO - 21 years

6.400

Employees

DexCom Inc. (United States) is listed on the Nasdaq and has a market capitalization of $33.79 billion, with shareholders equity totaling $2.62 billion.

The company employs approximately 6.400 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, DexCom Inc. reported $4.97 billion in revenue, generating net income of $999.70 million.

Key financial metrics include a P/E ratio of 33.80, a price-to-book (P/B) ratio of 12.89, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker DXCM.

Market cap

$33.79 billion

Net worth

$2.62 billion

$2,621,400,000.00

Assets

$6.46 billion

$6,455,300,000.00

Total Shares Outstanding

382.20 million

382,200,000

Average Daily Trading Volume

$4.63 million

$4,634,686.00

Sector

Health

Industry

Medical Supplies and Equipment

DXCM

revenue by Business Segment DexCom

Revenue by Region DexCom

DXCM revenue and profits

Financial Results DXCM

DRAG THE FRAME TO SEE MORE DATA

DXCM cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$95.95 40,88% (12M)

P/E

-0.87

2.73%

ROE

-178.93%

P/BV

1.56

CI - Cigna

$276.24 --5,64% (12M)

P/E

10.92

2.17%

ROE

16.04%

P/BV

1.75

CNC - Centene

$65.24 126,21% (12M)

P/E

-6.55

0.00%

ROE

-22.56%

P/BV

1.48

HUM - Humana

$403.48 31,88% (12M)

P/E

37.56

0.88%

ROE

6.72%

P/BV

2.52

SNY - Sanofi

$43.37 --3,69% (12M)

P/E

4.14

4.00%

ROE

18.43%

P/BV

0.76

LLY - Eli Lilly

$1,121.43 53,12% (12M)

P/E

38.25

0.56%

ROE

P/BV

HCA - HCA Healthcare

$402.41 --3,12% (12M)

P/E

11.38

0.74%

ROE

-244.72%

P/BV

-27.86

NVS - Novartis

$137.72 9,06% (12M)

P/E

23.95

1.94%

ROE

30.39%

P/BV

7.28